Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old
树突状细胞激活的细胞因子诱导的杀伤细胞介导的免疫疗法对65岁以上的癌症患者安全有效。
期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2016.5337
Liu, Yanfeng; Liu, Haibo; Liu, Hausheng; He, Pengcheng; Li, Jing; Liu, Xin; Chen, Limei; Wang, Mengchang; Xi, Jiejing; Wang, Huaiyu; Zhang, Haitao; Zhu, Ying; Zhu, Wei; Ning, Jing; Guo, Caili; Sun, Chunhong; Zhang, Mei
肿瘤
肿瘤免疫
树突状细胞
细胞生物学
树突状细胞
免疫/内分泌